This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXMPEA601E0_M.jpg
Bristol-Myers Squibb announced earnings per share of $1.63 on revenue of $10.13B. Analysts polled by Investing.com anticipated EPS of $1.49 on revenue of $9.95B.
Bristol-Myers Squibb shares are down 7% from the beginning of the year, still down 12.66% from its 52 week high of $68.34 set on January 22. They are under-performing the S&P Global (NYSE:SPGI) 100 which is up 4.26% from the start of the year.
Bristol-Myers Squibb’s report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on July 23 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.43B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
